All articles tagged with #metabolic surgery
This study compares the macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity, highlighting the potential benefits and data sharing protocols, with references to related research and long-term outcomes.
A new study has found that GLP-1 drugs, such as liraglutide, can help people who have undergone bariatric surgery but did not achieve their weight loss goals. These drugs suppress appetite and improve glucose, cholesterol, and blood pressure levels, contributing to weight loss. The study showed that taking liraglutide led to significant reductions in body fat and weight, as well as positive changes in other health markers. GLP-1 drugs act on the same mechanisms as bariatric surgery and can be used to optimize surgery outcomes.